Outcome of Board Meeting
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company, at their meeting held on February 12, 2014, have appointed Dr. Sridhar Ganesan as an Additional Director of the Company.17-02-2014
17-02-2014
Financial Results & Limited Review for Dec 31, 2013
Caplin Point Laboratories Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2013.12-02-2014
Clarification
With reference to Increase in Price, Caplin Point Laboratories Ltd has clarified to BSE that "the Company had recently concluded its Annual General Meeting for the year ended June 30, 2013 on the December 27, 2013 and in accordance with the recommendation of the Board, the Members of the Company had approved a payment of final Dividend of 25% (Rs. 2.50 paise per share of 10/-) for the year ended June 30, 2013 and is in the process of distribution...09-01-2014
Outcome of AGM ((Clause 35A)
Caplin Point Laboratories Ltd has informed BSE regarding the details of Voting results at the Annual General Meeting (AGM) of the Company held on December 27, 2013, under Clause 35A.30-12-2013
Fixes Book Closure for Final Dividend & AGM
Caplin Point Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from December 21, 2013 to December 27, 2013 (both days inclusive) for the purpose of Payment of Final Dividend & 22nd Annual General Meeting (AGM) of the Company to be held on December 27, 2013.09-12-2013
Limited Review for Sept 30, 2013
Caplin Point Laboratories Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended September 30, 2013.07-11-2013
Financial Results for Sept 30, 2013
Caplin Point Laboratories Ltd has informed BSE about the Financial Results for the period ended September 30, 2013.07-11-2013
Board recommends Final Dividend
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 16, 2013, inter alia, has considered and approved the recommendation of final dividend of Rs. 2.50 (Rupees Two and Paise Fifty only) per share (25%) on the equity capital of Rs. 10/- each for the year ended June 30, 2013 subject to the approval of the Shareholders in the ensuing Annual General Meeting.16-08-2013
Financial Results for June 30, 2013 (Audited)
Caplin Point Laboratories Ltd has informed BSE about the Financial Results for the period ended June 30, 2013.16-08-2013